Is there a role for 99mTc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?

Quarterly Journal of Nuclear Medicine

Volumn 47, Issue 2, 2003, Pages 109-115

  Fuster, D ^a,b   Maurel, J ^a   Muxi A ^a,b   Setoain, X ^a   Ayuso, C ^a   Martin F ^a   Ortega, M L ^a   Fuertes, S ^a   Pons, F ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Antibodies, monoclonal; Carcinoembryonic antigen; Colonic neoplasms, radionuclide imaging; Radioimmunodetection; Rectal neoplasms, radionuclide imaging

Indexed keywords

ARCITUMOMAB TC 99M; CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY TC 99M; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE; IOHEXOL; IOPROMIDE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ABDOMEN; ABDOMINAL DISEASE; ADULT; AGED; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BONE METASTASIS; CANCER RECURRENCE; CLINICAL TRIAL; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMMUNOSCINTIGRAPHY; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; PELVIC DISEASE; PELVIS; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; THORAX; THORAX DISEASE; VALIDATION PROCESS;

AGED; ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0041523953     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. August DA, Ottow RT, Sugarbaker PH. Clinical perspectives on human colorectal cancer metastasis. Cancer Metastasis Rev 1984;3:303-24.
2. Alabaster O. Colorectal cancer: Epidemiology, risks and prevention. In: Ahlgren JD, Macdonald JS, editors. Gastrointestinal Oncology. Philadelphia, PA: Lippincott; 1992.p.100-14.
3. Moertel CG, Fleming TR, Macdonald JS, Haller DJ, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993;270:943-7.
4. Vallejo J, Torres-Avisbal M, Contreras P, Rodriguez-Linan M, Rebollo A, Gonzalez F et al. CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis. Rev Esp Med Nucl 1999;18:281-6.
5. Schlag P, Lehner B, Strauss LG, Georgi P, Herfarth C. Scar or recurrent rectal cancer. Position emission tomography is more helpful for diagnosis than immunoscintigraphy. Arch Surg 1989;124:197-200.
6. Goldenberg DM, DeLand F, Kim E, Bennet S, Primus FJ, Van Nagell JR et al. Use of radiolabeled antibodies to carcinoembrionic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 1978;298:1384-8.
7. 99mTc-labelled anti-CEA monoclonal antibody (BW 431/26). Nucl Med Commun 1992;13:261-70.
8. Podoloff DA, Patt YS, Curley SA, Kim EE, Bhadkamkar VA, Smith RE. Imaging of colorectal carcinoma with technetium 99m radiolabeled Fab' fragments. Semin Nucl Med 1993;23:89-98.
9. Carrasquillo JA, Sugarbaker P, Colcher D, Reynolds JC, Esteban J, Bryant G et al. Radioimmunoscintigraphy of colon cancer with iodine-131 labelled B72.3 monoclonal antibody. J Nucl Med 1988;29:1022-30.
10. 111In-labeled monoclonal antibody immunoscintigraphy in colorectal carcinoma: Safety, sensitivity and preliminary clinical results. Radiology 1990;175:163-71.
11. 111In-labelled antiTAG-72 monoclonal antibody. Nucl Med Commun 1993;14:775-87.
12. Bischof A. Radioimmunoimaging and radioimmunotherapy: Will these be routine procedures. Semin Nucl Med 2000;3:186-94.
13. 111In labeled CYT-103 in the management of colorectal cancer: Comparison with CT. Radiology 1992;185:179-16.
14. Mach JP, Carrel S, Forni M, Ritschard J, Donath A, Alberto P. Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma. N Engl J Med 1980;303:5-10.
15. Nabi HA, Doerr RJ. Radiolabeled monoclonal antibody imaging (immunoscintigraphy) of colorectal cancers: Current status and future perspectives. Am J Surg 1992;163:448-56.
16. 99mTc in a patient with Paget's disease during a study of sigma cancer relapse. Rev Esp Med Nucl 2001;20:155-6.
17. Behr TM, Sharkey RM, Juweid MI, Dunn RM, Ying Z, Zhang CH et al. Factors influencing the pharmacokinetics, dosimetry and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcioembryonic antigen-expressing tumors. Cancer Res 1996;56:1805-16.
18. Stomper PC, D'Souza DJ, Bakshi SP, Rodriguez-Bigas M, Burke PA, Petrelli NJ. Detection of pelvic recurrence of colorectal carcinoma: Prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT. Radiology 1995;197:688-92.
19. Baulieu F, Bourlier P, Scotto B, Mor C, Eder V, Picon L. The value of immunoscintigraphy in the detection of recurrent colorectal cancer. Nucl Med Commun 2001;22:1295-304.
20. 99mTc-IMMU4 imaging in recurrent colorectal cancer: Efficacy and impact on surgical management. Nucl Med Commun 1996;17:568-76.
21. 99mTc-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: 2 year follow-up. Nucl Med Commun 1999;20:859-65.
22. Vitola JV, Delbeke D, Sandler MP, Campbell MG, Powers TA, Wright JK et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996;171:21-6.
23. Ruers TJ, Langenhoff BS, Neeleman N, Jager GJ, Strijk S, Wobbes T et al. Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorectal liver metastases: A prospective study. J Clin Oncol 2002;20:388-95.
24. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using non-invasive imaging methods (US, CT, MR imaging, PET): A meta-analysis. Radiology 2002;224:748-56.
25. Behr TM, Becker WS, Bair HJ, Klein MW, Stuhler CM, Cidlinsky KP et al. Comparison of complete versus fragmented technetium-99m-labelled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer. J Nucl Med 1995;36:430-41.
26. Bischof-Delaloye A, Delaloye B, Buchegger F, Gilgien W, Studer A, Curchod S et al. Clinical value of immunoscintigraphy in colorectal carcinoma patients: A prospective study. J Nucl Med 1989;30:1646-56.
27. Oliva JP, Pimentel G, Borron M, Peralta R, Ortiz R, Oliver B et al. Pilot study with the monoclonal antibody IOR-C5 as a potential agent of radioimmunoscintigraphy in colorectal cancer. Rev Esp Med Nucl 2001;20:282-8.
28. 99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: Novel imaging agents for rapid in vivo localization of human colon carcinoma. J Nucl Med 2001;42:1528-9.
29. 123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer. Br J Cancer 1998;78:1-5.
30. Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000;41:1177-89.
31. 18F]FDG PET in patients with suspected or confirmed recurrence of colorectal: A prospective study. J Nucl Med 2002;43:492-9.
32. Zervos EE, Badgwell BD, Burak WE, Arnold MW, Martin EW. Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup. Surgery 2001;130:636-43.
33. Arulampalam TH, Costa DC, Bomanji JB, Ell PJ. The clinical application of positron emission tomography to colorectal cancer management. Q J Nucl Med 2001;45:215-30.
34. 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. J Nucl Med 2000;41:1657-63.